Elena Giardino

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 154 citations · Full text

Alzheimer's Disease, Open-label Extension Study, Medicine +5

Dopamine receptor type 2 (<scp>DRD2</scp>) and somatostatin receptor type 2 (<scp>SSTR2</scp>) agonists are effective in inhibiting proliferation of progenitor/stem‐like cells isolated from nonfunctioning pituitary tumors

Erika Peverelli, Elena Giardino, Donatella Treppiedi et al. · International Journal of Cancer · 2017 · 59 citations · Full text

Filamin A (FLNA) Plays an Essential Role in Somatostatin Receptor 2 (SST2) Signaling and Stabilization After Agonist Stimulation in Human and Rat Somatotroph Tumor Cells

Erika Peverelli, Elena Giardino, Donatella Treppiedi et al. · Endocrinology · 2014 · 51 citations · Full text

Cancer Biology, Tumor Biology, Endocrine Oncology +20

Cyclic adenosine 3′-5′-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac)

Eleonora Vitali, Erika Peverelli, Elena Giardino et al. · Molecular and Cellular Endocrinology · 2013 · 37 citations

Pituitary Cells, Signal Transduction, Molecular Physiology +14

Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: First Italian series

Francesca Marta Elli, Anna Maria Barbieri, Paolo Bordogna et al. · Bone · 2013 · 35 citations · Full text

Progressive Osseous Heteroplasia, Developmental Biology, Somatic Variant +11